Alzamend Neuro, Inc. (ALZN)
NASDAQ: ALZN · Real-Time Price · USD
1.560
-0.070 (-4.29%)
At close: Aug 21, 2026, 4:00 PM EDT
1.580
+0.020 (1.28%)
After-hours: Aug 21, 2026, 7:50 PM EDT
Alzamend Neuro Market Cap
Alzamend Neuro has a market cap or net worth of $7.47 million as of August 21, 2026. Its market cap has increased by 5.34% in one year.
Market Cap
7.47M
Enterprise Value
6.76M
1-Year Change
5.34%
Ranking
Category
Stock Price
$1.56
ChartMarket Cap Chart
Since the IPO on June 15, 2021, Alzamend Neuro's market cap has decreased from $1.15B to $7.47M, a decrease of -99.35%. That is a compound annual growth rate of -62.11%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2026 | 7.47M | 8.03% |
| Dec 31, 2025 | 6.92M | 9.79% |
| Dec 31, 2024 | 6.30M | -0.56% |
| Dec 29, 2023 | 6.34M | -88.37% |
| Dec 30, 2022 | 54.47M | -67.73% |
| Dec 31, 2021 | 168.82M | -85.28% |
| Jun 15, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Traws Pharma | 8.07M |
| Aprea Therapeutics | 8.06M |
| Azitra | 8.05M |
| Immuron | 7.96M |
| Ernexa Therapeutics | 7.93M |
| AIM ImmunoTech | 7.87M |
| Acurx Pharmaceuticals | 7.75M |
| Can-Fite BioPharma | 7.70M |